东诚药业：已回购402.87万股，使用资金总额5717.19万元

Core Viewpoint - Dongcheng Pharmaceutical announced a share buyback plan, repurchasing 4,028,699 shares, which represents 0.49% of the total share capital, with a total expenditure of approximately RMB 57.17 million [1] Group 1 - The company conducted the share buyback through a dedicated securities account via centralized bidding [1] - The highest transaction price during the buyback was RMB 14.74 per share, while the lowest was RMB 13.87 per share [1] - The buyback aligns with relevant laws and regulations as well as the company's established share repurchase plan [1]